Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,886.24
(
1.02%
)
US TECH 100
24,753.20
(
1.27%
)
Dow Jones
48,218.25
(
0.63%
)
Brent Oil
94.35
(
-1.17%
)
Bitcoin
74,268.32
(
-0.31%
)
News Focus
News Focus
Post# of 257403
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122865
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 234117

Wednesday, 11/22/2023 11:15:59 AM

Wednesday, November 22, 2023 11:15:59 AM

Post# of 257403
SYNC.L acquires FRLN for $6.50/ADS—a 51% premium to the “unaffected” share price on 10/17/23:

https://www.globenewswire.com/news-release/2023/11/22/2784727/0/en/Syncona-to-Acquire-Freeline-Therapeutics.html

The nominal deal value is $28M.

The buyout price of $6.50 is a 64% discount to FRLN’s IPO in 2020 (#msg-157451134).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up